Questcor Pharmaceuticals (NASDAQ:QCOR)

CAPS Rating: 2 out of 5

A pharmaceutical company that focuses on novel therapeutics for the treatment of diseases and disorders of the central nervous system.

Recs

0
Player Avatar Turtlebale (53.18) Submitted: 7/11/2012 9:24:59 AM : Outperform Start Price: $46.30 QCOR Score: -65.75

oversold on short report

Report this Post Reply

Featured Broker Partners


Advertisement